Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Palbociclib | 3.1623 | uM | 4 | 312.50 | 138.79 | 179.00 | 312.25 | 0.5733 | 0.2430 |
| BT-20 | Omipalisib | 0.0033113 | uM | 4 | 312.50 | 138.79 | 304.00 | 312.25 | 0.9736 | 0.9547 |
| BT-20 | Methotrexate | 0.1 | uM | 4 | 312.50 | 138.79 | 314.00 | 312.25 | 1.0056 | 1.0096 |
| BT-20 | Omipalisib | 10 | uM | 4 | 312.50 | 138.79 | 39.00 | 312.25 | 0.1249 | -0.6622 |
| BT-20 | Methotrexate | 1 | uM | 4 | 312.50 | 138.79 | 304.00 | 312.25 | 0.9736 | 0.9547 |
| BT-20 | Methotrexate | 0.0033113 | uM | 4 | 312.50 | 138.79 | 220.00 | 312.25 | 0.7046 | 0.4826 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 249.00 | 312.25 | 0.7974 | 0.6481 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 237.00 | 312.25 | 0.7590 | 0.5800 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 211.00 | 312.25 | 0.6757 | 0.4306 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 262.00 | 312.25 | 0.8391 | 0.7214 | |
| BT-20 | Taxol | 0.01 | uM | 4 | 312.50 | 138.79 | 90.00 | 312.25 | 0.2882 | -0.3095 |
| BT-20 | Taxol | 0.1 | uM | 4 | 312.50 | 138.79 | 107.00 | 312.25 | 0.3427 | -0.1994 |
| BT-20 | Methotrexate | 0.31623 | uM | 4 | 312.50 | 138.79 | 290.00 | 312.25 | 0.9287 | 0.8775 |
| BT-20 | Taxol | 0.00016596 | uM | 4 | 312.50 | 138.79 | 318.00 | 312.25 | 1.0184 | 1.0314 |
| BT-20 | Palbociclib | 19.9526 | uM | 4 | 312.50 | 138.79 | 138.00 | 312.25 | 0.4420 | -0.0049 |
| BT-20 | Omipalisib | 0.1 | uM | 4 | 312.50 | 138.79 | 97.00 | 312.25 | 0.3107 | -0.2638 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 461.00 | 312.25 | 1.4764 | 1.7904 | |
| BT-20 | Palbociclib | 1 | uM | 4 | 312.50 | 138.79 | 154.00 | 312.25 | 0.4932 | 0.0930 |
| BT-20 | Omipalisib | 3.1623 | uM | 4 | 312.50 | 138.79 | 63.00 | 312.25 | 0.2018 | -0.4910 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 426.00 | 312.25 | 1.3643 | 1.6083 | |
| BT-20 | Omipalisib | 1 | uM | 4 | 312.50 | 138.79 | 91.00 | 312.25 | 0.2914 | -0.3029 |
| BT-20 | Methotrexate | 0.0016596 | uM | 4 | 312.50 | 138.79 | 348.00 | 312.25 | 1.1145 | 1.1942 |
| BT-20 | Palbociclib | 0.01 | uM | 4 | 312.50 | 138.79 | 322.00 | 312.25 | 1.0312 | 1.0533 |
| BT-20 | Taxol | 0.001 | uM | 4 | 312.50 | 138.79 | 286.00 | 312.25 | 0.9159 | 0.8554 |
| BT-20 | Methotrexate | 0.01 | uM | 4 | 312.50 | 138.79 | 292.00 | 312.25 | 0.9352 | 0.8886 |